CLASS II Device recall · Reported 14 Mar 2018 · FDA Enforcement Report

Signature Ceramic Femoral Head recalled by Signature Orthopedics Pty

Signature Orthopedics is recalling Signature Ceramic Femoral Head, distributed nationwide in the US. The recall was initiated on 2 Feb 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesUDI: 09348215001926. Lot:78560.
Quantity recalled10

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0920-2018
FDA event ID
79219
Recalling firm
Signature Orthopedics, Sydney, N/A
Classification
Class II
Status
Terminated
Recall initiated
2 Feb 2018
FDA classified
6 Mar 2018
Reported
14 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Labeling Errors

Timeline

2 Feb 2018Recall initiated by company
6 Mar 2018Classified by FDA+32 days
14 Mar 2018Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

This recall has been identified due to the batch being mislabeled, with the packaged component's size not corresponding to the label. Therefore, the product intended to be used for the procedure may not be included in the packaging resulting in surgical delay as replacement product is retrieved.

Product as listed by the FDA

Signature Ceramic Femoral Head. Model Number: 111-152-621. The Signature ceramic femoral heads are manufactured by Ceramtec from 72-75% Al2O3+24-26% Z3O3 (Biolox Delta). The heads connect via a 12/14 taper to the stem trunnion, and articulates against the crosslinked UHMWPE liner within the Logical Acetabular Cups. Product Usage: Components of the Signature Orthopaedics hip replacement range are intended to replace a hip joint where bone stock is sufficient to support the implant. When a surgeon has selected prosthetic replacement as the preferred treatment, the devices are indicated for: ¿ Non-inflammatory degenerative joint disease including osteoarthritis or avascular necrosis ¿ Inflammatory joint disease including rheumatoid arthritis ¿ Correction of functional deformity including congenital hip dysplasia ¿ Traumatic injury involving the hip joint including traumatic arthritis or femoral head or neck fracture ¿ Failed previous hip surgery including internal fixation or joint fusion, reconstruction, hemiarthroplasty, surface replacement, or total replacement

Where it was distributed

Worldwide Distribution - U.S. Nationwide and the country of Australia.

Nationwide

Questions about this recall

Why was it recalled?

This recall has been identified due to the batch being mislabeled, with the packaged component's size not corresponding to the label. Therefore, the product intended to be used for the procedure may not be included in the packaging resulting in surgical delay as replacement product is retrieved.

Which lots are affected?

UDI: 09348215001926. Lot:78560.

Where was it sold?

Worldwide Distribution - U.S. Nationwide and the country of Australia.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Signature Orthopedics

All 4

Other Heart & Vascular Devices recalls

All 6,199